Aetna Adds IVF Coverage For Same-Sex Couples After Settlement
U.S. District Judge Haywood Gilliam, Jr. approved the agreement. Aetna will now cover IVF treatment for same-sex couples in the same way as heterosexual couples. This policy change will be applied nationally, and will benefit an estimated 2.8 million members.
CalMatters:
Aetna To Cover IVF Treatments For Same-Sex Couples In National Settlement
Last week, in a landmark settlement, U.S. District Judge for the Northern District of California Haywood Gilliam, Jr. approved a preliminary agreement for the class action lawsuit requiring Aetna to cover fertility treatments for same-sex couples — like artificial insemination or in vitro fertilization — as they do with heterosexual couples. It is the first case requiring a health insurer to apply this policy nationally across all of its enrollees. An estimated 2.8 million LGBTQ members will benefit, including 91,000 Californians. Under the settlement, Aetna will also pay at least $2 million in damages to California-based members who qualify. (Hwang, 12/22)
MedPage Today:
Nirsevimab Might Top Maternal Vax For Infants' RSV Protection
Infants given the monoclonal antibody nirsevimab (Beyfortus) to provide passive immunity against respiratory syncytial virus (RSV) had a lower rate of related hospitalizations and severe outcomes than those whose mothers got immunized with the RSVpreF vaccine (Abrysvo), a population-based cohort study from France indicated. (Henderson, 12/22)
CIDRAP:
Mpox Infection Early In Pregnancy Linked To Poor Fetal Outcomes, Study Suggests
A prospective cohort study from the Democratic Republic of the Congo (DRC) suggests that mpox infection during pregnancy, particularly in the first trimester, is associated with a high risk of fetal loss. The study, published late last week in The Lancet, pooled data from four studies conducted between December 2022 and June 2025 in one DRC region where mpox clade 1b is in circulation and two regions in which mpox clade 1a is endemic. (Bergeson, 12/22)
MedPage Today:
Benzodiazepines Linked With Adverse Pregnancy Outcomes
Use of benzodiazepines during pregnancy, particularly in the second trimester, was linked to some adverse pregnancy outcomes, a Taiwanese cohort study found. (Robertson, 12/22)
CIDRAP:
European Report Calls On Countries To Update Strategies On Sexually Transmitted Infections
A new report by European health officials indicates outdated national strategies and gaps in testing are hindering European countries’ efforts to stem a continent-wide surge in sexually transmitted infections (STIs). (Dall, 12/22)
